Article
NKG2D-ligands: Putting everything under the same umbrella can be misleading.
HLA - 1 Jun 2018
Campos-Silva C, Kramer M K, Valés-Gómez M
Abstract excerpt
NKG2D is a key receptor for the activation of immune effector cells, mainly Natural Killer cells and T lymphocytes, in infection, cancer and autoimmune diseases. Since the detection of ligands for NKG2D in sera of cancer patients is, in many human models, indicative of prognosis, a large number of studies have been undertaken to improve understanding of the biology regulating this receptor and its ligands, with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
